TB-500

TB-500 is a synthetic fragment of Thymosin Beta-4 containing the actin-binding domain (amino acids 17-23: LKKTETQ) that is central to Tβ4's proposed role in cell migration and tissue remodeling. Thymosin Beta-4 is one of the most abundant actin-sequestering proteins, and TB-500 replicates its experimentally relevant bioactive region.

Research applications include cell migration assays, wound healing biology, angiogenesis studies, cardiac tissue remodeling research, and comparative Thymosin Beta-4 pharmacology. TB-500 is used alongside BPC-157 in dual-peptide tissue repair research designs.

Every batch of TB-500 is synthesized using Solid-Phase Peptide Synthesis (SPPS) and purified via preparative HPLC to eliminate truncated sequences and synthesis byproducts. Final identity confirmation is performed via Electrospray Ionization Mass Spectrometry (ESI-MS), verifying exact molecular weight. Each lot ships with a Certificate of Analysis documenting purity exceeding 99%, giving researchers traceable, batch-specific verification before use in any laboratory protocol.

This product is strictly for research and laboratory use only. It is not approved by the FDA or any global regulatory body for human consumption, veterinary use, or therapeutic application. The purchaser assumes all responsibility for the proper handling, storage, and application of this compound. It must only be handled by qualified professionals in a controlled laboratory setting. By purchasing this product, you agree to abide by all local and international laws regarding the use of research chemicals.